Expression of the recombinant major allergen of salsola kali pollen (Sal k 1) and comparison with its low-immunoglobulin E-binding mutant

Allergology International

Volumn 59, Issue 2, 2010, Pages 213-222

  Assarehzadegan, Mohammad A ^a,b   Sankian, Mojtaba ^a,b   Jabbari, Farahzad ^b   Tehrani, Mohsen ^b   Varasteh, Abdolreza ^a,b,c,d  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Bu Ali Research Institute   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Varastegan Institute for Medical Sciences   (Iran)

Author keywords

Comparison; Expression; Mutant; Sal k 1; Salsola kali

Indexed keywords

HISTIDINE; IMMUNOGLOBULIN E; RECOMBINANT ALLERGEN; RECOMBINANT PROTEIN SAL K 1; THIOREDOXIN; UNCLASSIFIED DRUG; HYBRID PROTEIN; PLANT ANTIGEN; PROTEIN BINDING;

ADULT; AFFINITY CHROMATOGRAPHY; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; MALE; NUCLEOTIDE SEQUENCE; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; SALSOLA; SALSOLA KALI; GENETICS; HAY FEVER; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MUTATION; SITE DIRECTED MUTAGENESIS;

ADULT; ANTIGENS, PLANT; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MUTAGENESIS, SITE-DIRECTED; MUTATION; POLLEN; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RHINITIS, ALLERGIC, SEASONAL; SALSOLA;

EID: 77954561679     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.09-OA-0155     Document Type: Article

References (29)

1. Shafiee A, Yunginger JW, Gleich GJ. Isolation and characterization of Russian thistle (Salsola pestifer) pollen allergens. J Allergy Clin Immunol 1981; 67:472-481.
2. Al-Dowaisan A, Fakim N, Khan MR et al. Salsola pollen as a predominant cause of respiratory allergies in Kuwait. Ann Allergy Asthma Immunol 2004; 92:262-267.
3. Colas C, Monzon S, Venturini M et al. Correlation between Chenopodiacea/Amaranthacea pollen counts and allergic symptoms in Salsola kali monosensitized patients. JInvestig Allergol Clin Immunol 2005; 15:254-258.
4. Assarehzadegan MA, Sankian M, Jabberi Azad F, Noor-bakhsh R, Varasteh A. Allergy to Salsola Kali in a Salsola incanescens-rich area: role of extensive cross allergenic-ity. Allergol Int 2009; 58:261-276.
5. Barderas R, Garcia-Selles J, Salamanca G et al. A pectin methylesterase as an allergenic marker for the sensitiza-tion to Russian thistle (Salsola kali) pollen. Clin Exp Allergy 2007; 37:1111-1129.
6. Suliaman FA, Holmes WF, Kwick S, Khouri F, Ratard R. Pattern of immediate type hypersensitivity reactions in the Eastern Province, Saudi Arabia. Ann Allergy Asthma Immunol 1997; 78:415-428.
7. Ezeamuzie CI, Thomson MS, Al-Ali S, Dowaisan A, Khan M, Hijazi Z. Asthma in the desert: spectrum of the sensitizing aeroallergens. Allergy 2000; 55:157-162.
8. Carnes J, Fernandez-Caldas E, Marina A et al. Immuno-chemical characterization of Russian thistle (Salsola kali) pollen extracts. Purification of the allergen Sal k 1. Allergy 2003; 58:1152-1166.
9. Van Do T, Hordvik I, Endresen C, Elsayed S. Expression and analysis of recombinant salmon parvalbumin, the major allergen in Atlantic salmon (Salmo salar). Scand J Immunol 1999; 50:619-625.
10. Bradford MM. A rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
11. Saha S, Raghava GP. Prediction of continuous B-cell epi-topes in an antigen using recurrent neural network. Proteins 2006; 65:40-48.
12. Saha S, Raghava GP. BcePred: Prediction of continuous B-Cell epitopes in antigenic sequences using physico-chemical properties. In: Nicosia G, Cutello V, Bentley PJ, Timis J (eds). Artificial Immune Systems. Berlin: Springer, 2004; 197-204.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
14. Mahler V, Fischer S, Heiss S, Duchene M, Kraft D, Valenta R. cDNA cloning and characterization of a cross-reactive birch pollen allergen: identification as a pectin es-terase. Int Arch Allergy Immunol 2001; 124:64-66.
15. Kondo Y, Urisu A, Tokuda R. Identification and characterization of the allergens in the tomato fruit by im-munoblotting. Int Arch Allergy Immunol 2001; 126:294-299.
16. Wurtzen PA, Nelson HS, Lowenstein H, Ipsen H. Characterization of Chenopodiales (Amaranthus retroflexus, Chenopodium album, Kochia scoparia, Salsola pestifer) pollen allergens. Allergy 1995; 50: 489-497.
17. Karisola P, Mikkola J, Kalkkinen N et al. Constructionof hevein (Hev b 6.02) with reduced allergenicity for immu-notherapy of latex allergy by comutation of six amino acid residues on the conformational IgE epitopes. J Immunol 2004; 172:2621-2638.
18. Marazuela EG, Rodriguez R, Barber D, Villalba M, Batan-ero E. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines. Clin Exp Allergy 2007; 37:251-260.
19. Swoboda I, Bugajska-Schretter A, Linhart B et al. Are-combinant hypoallergenic parvalbumin mutant for immu-notherapy of IgE-mediated fish allergy. JImmunol 2007; 178:6290-6296.
20. Takai T, Yokota T, Yasue M et al. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat Biotechnol 1997; 15:754-768.
21. Vrtala S, Hirtenlehner K, Vangelista L et al. Conversionof the major birch pollen allergen, Bet v 1, into two nonana-phylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. JClinInvest 1997; 99:1673-1681.
22. Takai T, Ichikawa S, Hatanaka H, Inagaki F, Okumura Y. Effects of proline mutations in the major house dust mite allergen Der f 2 on IgE-binding and histamine-releasing activity. Eur JBiochem 2000; 267:6650-6656.
23. Singh MB, Bhalla PL. Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination. Immunol Cell Biol 2003; 81:86-91.
24. Swoboda I, De Weerd N, Bhalla PL et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific im-munotherapy. Eur JImmunol 2002; 32:270-280.
25. Laskowski R, MacArthur M, Moss D, Thornoton J. PRO-CHECK: a program to check the stereochemical quality of protein structures. JAppl Cryst 1993; 26:283-291.
26. Ferreira F, Ebner C, Kramer B et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998;12: 231-242.
27. Westritschnig K, Focke M, Verdino P et al. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7. JImmunol 2004;172: 5684-5692.
28. Vrtala S, Akdis CA, Budak F et al. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. JImmunol 2000;165: 6653-6659.
29. Pauli G, Purohit A, Oster JP et al. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population. Clin Exp Allergy 2000;30:1076-1184.